Chinese Local Pharmas See Innovative Products As Future Growth Driver - China Healthcare Investment Conference
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Fueled by the Chinese government's latest five-year plan that will promote innovation and increase exports of finished products, Chinese domestic companies are increasing their R&D efforts to ensure future growth, companies said during the second annual China Healthcare Investment conference March 23